Gossamer Bio's total assets for Q3 2025 were $208.82M, a decrease of -13.33% from the previous quarter. GOSS total liabilities were $291.15M for the fiscal quarter, a 1.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.